# CNBP

## Overview
The CNBP gene encodes the CCHC-type zinc finger nucleic acid binding protein, a multifunctional protein that plays a significant role in nucleic acid metabolism. This protein is characterized by its CCHC-type zinc finger domains, which facilitate binding to single-stranded DNA and RNA, and is categorized as a nucleic acid binding protein. CNBP is involved in various cellular processes, including post-transcriptional gene regulation, where it enhances translational efficiency by interacting with G-rich elements in mRNA. It also functions as a nucleic acid chaperone, modulating the secondary structures of nucleic acids, and participates in immune response regulation. The CNBP gene is clinically significant due to its association with myotonic dystrophy type 2, a disorder linked to the expansion of CCTG repeats within the gene (Benhalevy2017The; Armas2021What’s; Alfano2022Characterization).

## Structure
The human CNBP (CCHC-type zinc finger nucleic acid binding protein) is characterized by its primary structure, which includes multiple CCHC-type zinc finger domains. These domains are crucial for its ability to bind nucleic acids, specifically single-stranded DNA and RNA. CNBP contains six to seven tandem CCHC-type 14-amino acid zinc knuckle motifs, which are similar to those found in the human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein (NCp) (Armas2021What’s). The protein also features an Arg/Gly (RG)-rich motif, which is essential for nucleic acid binding and chaperone activities (Armas2021What’s).

The secondary structure of CNBP is likely composed of beta sheets and alpha helices, stabilized by zinc ions coordinating with cysteine and histidine residues. The tertiary structure is flexible and intrinsically disordered, with structured zinc knuckles that become more rigid upon nucleic acid binding (Armas2021What’s). CNBP forms homodimers independently of nucleic acid binding, indicating a quaternary structure that enhances its stability in the presence of single-stranded nucleic acid targets (Armas2021What’s).

CNBP undergoes post-translational modifications, including phosphorylation, which affects its activity and subcellular localization (Armas2021What’s). The protein exists in multiple isoforms due to alternative splicing, with isoforms 3 and 6 being the most abundant in HEK293 human cells (Benhalevy2017The). These isoforms exhibit variations in the CCHC and RG-rich domains, influencing their functional properties (Benhalevy2017The).

## Function
The CNBP (CCHC-type zinc finger nucleic acid-binding protein) is a multifunctional protein involved in various cellular processes in healthy human cells. It primarily operates in the cytoplasm, where it plays a crucial role in post-transcriptional gene regulation by binding to G-rich elements in target mRNA coding sequences, thereby promoting translation (Benhalevy2017The). CNBP enhances translational efficiency by preventing the formation of stable secondary structures, such as G-quadruplexes, which can impede translation (Benhalevy2017The). This function is essential for maintaining proper ribosome dynamics and efficient protein synthesis (Benhalevy2017The).

CNBP also acts as a nucleic acid chaperone, facilitating the rearrangement of nucleic acid secondary structures in an ATP-independent manner, which can control transcription and translation (Armas2021What’s). It is involved in the immune response, modulating the expression of pro-inflammatory cytokines and acting as an antiviral regulator (Armas2021What’s). CNBP's ability to bind both single-stranded DNA and RNA allows it to influence transcriptional regulation, impacting the expression of immune-related and tumor-related genes (Armas2021What’s). Its diverse functions are linked to its role in pathologies like myotonic dystrophy type 2, where its expression and interactions are altered (Armas2021What’s).

## Clinical Significance
Mutations in the CNBP gene are primarily associated with myotonic dystrophy type 2 (DM2), also known as proximal myotonic myopathy (PROMM). DM2 is an autosomal dominant multisystem disorder characterized by progressive proximal muscle weakness, myotonia, myalgia, calf hypertrophy, and sclerosis, as well as frontotemporal dementia and cataracts (Soltanzadeh2022Myotonic; Alfano2022Characterization). The condition is caused by the expansion of CCTG repeats in intron 1 of the CNBP gene, with the number of repeats ranging from 75 to over 11,000 units (Alfano2022Characterizationa; Kamsteeg2012Best). These expansions exhibit extensive somatic mosaicism, which complicates the correlation between repeat length and disease severity (Alfano2022Characterizationa; Alfano2022Characterization).

The presence of uninterrupted CCTG tracts in the CNBP gene is a hallmark of DM2, although such tracts can also appear in healthy range alleles, potentially representing premutation alleles (Radvanszky2013Uninterrupted). The disease does not typically show genetic anticipation, and there is no significant association between the age of onset and the number of CCTG-repeat units (Kamsteeg2012Best). Alterations in CNBP expression or its interactions may impact cellular processes, contributing to the clinical manifestations of DM2 (Alfano2022Characterization).

## Interactions
The cellular nucleic acid binding protein (CNBP) is involved in various interactions with both nucleic acids and proteins. CNBP binds preferentially to RNA over DNA, with a higher affinity for purine-rich single-stranded DNA and G-rich RNA sequences. It interacts with the 5' untranslated region (UTR) of Xenopus laevis ribosomal protein mRNAs, particularly binding to conserved regions that are G C and G A-rich (Pellizzoni1997Cellular). CNBP also acts as a nucleic acid chaperone, promoting the unfolding of G-quadruplex (G4) structures in nucleic acids, such as those found in the SARS-CoV-2 RNA genome, potentially regulating viral protein translation (Armas2021What’s).

CNBP interacts with several proteins, including NM23-H2, a c-myc transcription activator. This interaction is crucial for the regulation of c-myc transcription, where CNBP binds to the c-myc G-quadruplex motif, influencing its formation and transcriptional activity (Chen2013Mechanistic). CNBP also interacts with the α subunit of the dystroglycan complex, affecting membrane stability in muscle fibers (Armas2021What’s). These interactions highlight CNBP's role in transcriptional regulation and its potential as a therapeutic target in cancer and other diseases.


## References


[1. (Alfano2022Characterization) Massimiliano Alfano, Luca De Antoni, Federica Centofanti, Virginia Veronica Visconti, Simone Maestri, Chiara Degli Esposti, Roberto Massa, Maria Rosaria D’Apice, Giuseppe Novelli, Massimo Delledonne, Annalisa Botta, and Marzia Rossato. Characterization of full-length cnbp expanded alleles in myotonic dystrophy type 2 patients by cas9-mediated enrichment and nanopore sequencing. eLife, August 2022. URL: http://dx.doi.org/10.7554/elife.80229, doi:10.7554/elife.80229. This article has 11 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.80229)

[2. (Benhalevy2017The) Daniel Benhalevy, Sanjay K. Gupta, Charles H. Danan, Suman Ghosal, Hong-Wei Sun, Hinke G. Kazemier, Katrin Paeschke, Markus Hafner, and Stefan A. Juranek. The human cchc-type zinc finger nucleic acid-binding protein binds g-rich elements in target mrna coding sequences and promotes translation. Cell Reports, 18(12):2979–2990, March 2017. URL: http://dx.doi.org/10.1016/j.celrep.2017.02.080, doi:10.1016/j.celrep.2017.02.080. This article has 107 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2017.02.080)

[3. (Chen2013Mechanistic) Siqi Chen, Lijuan Su, Jun Qiu, Nannan Xiao, Jing Lin, Jia-heng Tan, Tian-miao Ou, Lian-quan Gu, Zhi-shu Huang, and Ding Li. Mechanistic studies for the role of cellular nucleic-acid-binding protein (cnbp) in regulation of c-myc transcription. Biochimica et Biophysica Acta (BBA) - General Subjects, 1830(10):4769–4777, October 2013. URL: http://dx.doi.org/10.1016/j.bbagen.2013.06.007, doi:10.1016/j.bbagen.2013.06.007. This article has 37 citations.](https://doi.org/10.1016/j.bbagen.2013.06.007)

[4. (Soltanzadeh2022Myotonic) Payam Soltanzadeh. Myotonic dystrophies: a genetic overview. Genes, 13(2):367, February 2022. URL: http://dx.doi.org/10.3390/genes13020367, doi:10.3390/genes13020367. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes13020367)

[5. (Pellizzoni1997Cellular) Livio Pellizzoni, Francesco Lotti, Bruno Maras, and Paola Pierandrei-Amaldi. Cellular nucleic acid binding protein binds a conserved region of the 5′ utr of xenopus laevis ribosomal protein mrnas. Journal of Molecular Biology, 267(2):264–275, March 1997. URL: http://dx.doi.org/10.1006/jmbi.1996.0888, doi:10.1006/jmbi.1996.0888. This article has 88 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1006/jmbi.1996.0888)

[6. (Armas2021What’s) Pablo Armas, Gabriela Coux, Andrea M.J. Weiner, and Nora B. Calcaterra. What’s new about cnbp? divergent functions and activities for a conserved nucleic acid binding protein. Biochimica et Biophysica Acta (BBA) - General Subjects, 1865(11):129996, November 2021. URL: http://dx.doi.org/10.1016/j.bbagen.2021.129996, doi:10.1016/j.bbagen.2021.129996. This article has 13 citations.](https://doi.org/10.1016/j.bbagen.2021.129996)

7. (Alfano2022Characterizationa) Characterization of full-length CNBP expanded alleles in myotonic dystrophy type 2 patients by Cas9-mediated enrichment and nanopore sequencing. This article has 0 citations.

[8. (Radvanszky2013Uninterrupted) Jan Radvanszky, Milan Surovy, Emil Polak, and Ludevit Kadasi. Uninterrupted cctg tracts in the myotonic dystrophy type 2 associated locus. Neuromuscular Disorders, 23(7):591–598, July 2013. URL: http://dx.doi.org/10.1016/j.nmd.2013.02.013, doi:10.1016/j.nmd.2013.02.013. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.nmd.2013.02.013)

[9. (Kamsteeg2012Best) Erik-Jan Kamsteeg, Wolfram Kress, Claudio Catalli, Jens M Hertz, Martina Witsch-Baumgartner, Michael F Buckley, Baziel G M van Engelen, Marianne Schwartz, and Hans Scheffer. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. European Journal of Human Genetics, 20(12):1203–1208, May 2012. URL: http://dx.doi.org/10.1038/ejhg.2012.108, doi:10.1038/ejhg.2012.108. This article has 115 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2012.108)